Algorithmic Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.53 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -1.31%
- Profit Growth -20.78%
- Ebitda -86.75%
- Net Worth -16.48%
- Total Assets -17.75%
About Algorithmic Biologics
Algorithmic Biologics Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 March 2021 (Three years and 11 months 7 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.53 M, as per Ministry of Corporate Affairs (MCA) records.
Nidhi Mathur, Bhanu Vaddiparthi, and Manoj Gopalkrishnan serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100KA2021PTC144837
-
Company No.
144837
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Mar 2021
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Algorithmic Biologics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nidhi Mathur
|
Nominee Director | 13-Mar-2024 | Current |
|
Bhanu Vaddiparthi
|
Director | 03-Mar-2021 | Current |
|
Manoj Gopalkrishnan
|
Director | 03-Mar-2021 | Current |
Financial Performance of Algorithmic Biologics.
Algorithmic Biologics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.31% decrease. The company also saw a substantial fall in profitability, with a 20.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Algorithmic Biologics?
In 2023, Algorithmic Biologics had a public holding of 2.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Microbiotx Health Private LimitedNidhi Mathur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Algorithmic Biologics?
Algorithmic Biologics has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Algorithmic Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Algorithmic Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
